PG-102

PG-102 · ProGen. Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PG-102, covering 2025-09-23 to 2025-09-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Randomized Study of PG-102 vs Placebo and Semaglutide in Type 2 Diabetes Mellitus [Phase 2]